[go: up one dir, main page]

PE20081573A1 - Composiciones y metodos para tratar las convulsiones - Google Patents

Composiciones y metodos para tratar las convulsiones

Info

Publication number
PE20081573A1
PE20081573A1 PE2007001742A PE2007001742A PE20081573A1 PE 20081573 A1 PE20081573 A1 PE 20081573A1 PE 2007001742 A PE2007001742 A PE 2007001742A PE 2007001742 A PE2007001742 A PE 2007001742A PE 20081573 A1 PE20081573 A1 PE 20081573A1
Authority
PE
Peru
Prior art keywords
seizures
compositions
methods
agent
treat seizures
Prior art date
Application number
PE2007001742A
Other languages
English (en)
Inventor
David Bortz
R Saul Levinson
Jeremy Donald Wang
Jisheng Ge
Original Assignee
Drugtech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugtech Corp filed Critical Drugtech Corp
Publication of PE20081573A1 publication Critical patent/PE20081573A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONTIENE UNO O MAS AGENTES ANTI-CONVULSION AGUDA, SIENDO PREFERIDO COMO PRIMER AGENTE ANTI-CONVULSION EL GRUPO SELECCIONADO DE DIAZEPAM, CLONAZEPAM, LORAZEPAM, MIDAZOLAM, ENTRE OTROS Y COMO SEGUNDO AGENTE SELECCIONADO DE FENOBARBITAL, FENITOINA, ENTRE OTROS; ADEMAS COMPRENDE UNO O MAS INCREMENTADORES DE PERMEACION. ESTA COMPOSICION ES BIOADHERENTE A LA MUCOSA ORAL Y/O NASAL HUMANA, BAJO LA FORMA DE DOSIFICACION LIQUIDA, SEMISOLIDA Y SOLIDA, PRESENTANDOSE EN FORMA DE UNA PELICULA U OBLEA, SIENDO UTIL PARA EL TRATAMIENTO DE LAS CONVULSIONES REPETIDAS Y ESTADO EPILEPTICO
PE2007001742A 2006-12-07 2007-12-07 Composiciones y metodos para tratar las convulsiones PE20081573A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86906706P 2006-12-07 2006-12-07

Publications (1)

Publication Number Publication Date
PE20081573A1 true PE20081573A1 (es) 2008-12-05

Family

ID=39512403

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001742A PE20081573A1 (es) 2006-12-07 2007-12-07 Composiciones y metodos para tratar las convulsiones

Country Status (5)

Country Link
US (1) US20080138383A1 (es)
AR (1) AR064185A1 (es)
CL (1) CL2007003561A1 (es)
PE (1) PE20081573A1 (es)
WO (1) WO2008073779A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
JP2010535775A (ja) * 2007-08-10 2010-11-25 リトル ビジー ボディーズ， インコーポレイテッド 生理食塩水ノーズワイプ及びその製造方法と使用方法
DE102008004694A1 (de) * 2008-01-16 2009-07-23 Gesellschaft für medizinische Forschung und Weiterbildung e.V. (GMF) Benzodiazepin und/oder Benzodiazepinderivate enthaltende pharmazeutische Zusammensetzung
GB201007290D0 (en) * 2010-04-30 2010-06-16 R5 Pharmaceuticals Ltd Pharmaceutical powder compositions
JP2015227288A (ja) * 2012-08-31 2015-12-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 けいれん重積発作の治療用医薬組成物
EP2759290B1 (de) * 2013-01-24 2019-11-06 Merz Pharma GmbH & Co. KGaA Sprühbare flüssige zubereitung zur nasalen anwendung mit erhöhter lokaler verweilzeit

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551148A (en) * 1982-09-07 1985-11-05 Kv Pharmaceutical Company Vaginal delivery systems and their methods of preparation and use
US6150400A (en) * 1997-06-30 2000-11-21 Presutti Laboratories Method for treating vulvar vestibulitis
US5888523A (en) * 1997-09-22 1999-03-30 Biocontrol, Inc. Topical non-steroidal anti-inflammatory drug composition
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
US6756051B1 (en) * 2000-11-15 2004-06-29 Li-Lan H. Chen Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same
GB0130964D0 (en) * 2001-12-24 2002-02-13 Special Products Ltd Pharmaceutical composition
WO2004041118A2 (en) * 2002-10-31 2004-05-21 Umd, Inc. Therapeutic compositions for drug delivery to and through covering epithelia

Also Published As

Publication number Publication date
CL2007003561A1 (es) 2008-05-16
WO2008073779A3 (en) 2009-04-30
US20080138383A1 (en) 2008-06-12
WO2008073779A2 (en) 2008-06-19
AR064185A1 (es) 2009-03-18

Similar Documents

Publication Publication Date Title
PE20081573A1 (es) Composiciones y metodos para tratar las convulsiones
CO6290631A2 (es) Composición oral que contiene amino ácidos y un agente blanqueador
PE20081114A1 (es) Composiciones farmaceuticas bioadhesivas de agente dual para uso topico
ECSP088763A (es) Nuevas combinaciones terapéuticas para el tratamiento de la depresión
GT200700034A (es) Composiciones farmaceuticas de antagonistas del anticuerpo anti-cd40
BRPI0822162B8 (pt) composição farmacêutica para tratamento tópico de doença das unhas ou leito ungueal
CL2007002228A1 (es) Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composiicon empacada; metodos para esterelizarlas; util para cicatrizar tejido donde la dermis se ha desgarrado.
BRPI0714399B8 (pt) composição farmacêutica líquida oral
MX337422B (es) Composiciones y metodos para incrementar la sencibilidad a la insulina.
BRPI0809164B8 (pt) Composição para administração tópica e composição farmacêutica compreendendo a referida composição
AR062511A1 (es) Formas de dosificacion farmaceutica
BRPI0918313A2 (pt) Agente antiperspirante multicomponente, processo para tratar a perspiração humana, uso de um agente multicomponente e dispositivo com múltiplos compartimentos ou kit
EP2485720A4 (en) LOW-ETHER COMPOSITION AND ADMINISTRATION APPARATUS
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
SV2009003335A (es) Formulaciones para el cancer
EA201201569A1 (ru) Инъекционная композиция пролонгированного действия для введения антипсихотического препарата
PE20090113A1 (es) Compuestos triciclicos como moduladores del receptor de glucocorticoides, composiciones y procedimientos
BRPI0710483A8 (pt) composições e kits úteis para o tratamento de doenças respiratórias
MX361778B (es) Composiciones farmaceuticas y metodos de tratamiento.
CL2009002129A1 (es) Derivados carboxiamida de lantibioticos; proceso de preparacion de dichos lantibioticos; composicion farmaceutica que lo contiene; utiles en el tratamiento de infecciones bacterianas.
CL2009000084A1 (es) Compuestos derivados de sulfonamida sustituida, moduladores de receptores de bradiquinina; composicion farmaceutica que contiene a los compuestos; y uso en el tratamiento del dolor agudo, neuropatico o cronico, entre otros.
CL2010000829A1 (es) Metodo para tratar plantas que comprende aplicar a las plantas una composicion liquida que contiene ente 0,3 a 300 miligramos de uno o mas ciclopropenos por litro de dicha composicion.
CL2008002082A1 (es) Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades.
AR112818A1 (es) Fabricación de composiciones farmacéuticas que comprenden uno o más de estos: un péptido, una proteína y un anticuerpo
EA200901061A1 (ru) Фармацевтические и косметические композиции для ускорения процесса заживления ран и других поверхностных повреждений

Legal Events

Date Code Title Description
FD Application declared void or lapsed